Creo Medical Limited is a UK-based limited company established in 2003, currently registered under SIC code 04658880. The company specializes in research and experimental development within the natural sciences and engineering sectors. Creo Medical focuses on developing innovative medical devices and software, primarily centered around image-guided surgery and diagnostic imaging. Their core expertise lies in advanced imaging technologies, including optical coherence tomography (OCT) and ultrasound. The company’s primary service offerings encompass the design and development of novel imaging systems, software solutions, and related technologies. Creo Medical’s activities are primarily focused on enhancing patient outcomes through improved diagnostic accuracy and surgical precision. While the company’s specific size is not publicly available, it operates within a range of research and development activities, potentially including collaborations with academic institutions and industry partners. Creo Medical maintains a significant international presence, with operations extending globally. The company’s key focus is on advancing medical technology and contributing to the healthcare industry. It utilizes a hiring indicator of “yes” for personnel and resources.

Creo Medical Limited is a UK-based limited company established in 2003, currently registered under SIC code 04658880. The company specializes in research and experimental development within the natural sciences and engineering sectors. Creo Medical focuses on developing innovative medical devices and software, primarily centered around image-guided surgery and diagnostic imaging. Their core expertise lies in advanced imaging technologies, including optical coherence tomography (OCT) and ultrasound. The company’s primary service offerings encompass the design and development of novel imaging systems, software solutions, and related technologies. Creo Medical’s activities are primarily focused on enhancing patient outcomes through improved diagnostic accuracy and surgical precision. While the company’s specific size is not publicly available, it operates within a range of research and development activities, potentially including collaborations with academic institutions and industry partners. Creo Medical maintains a significant international presence, with operations extending globally. The company’s key focus is on advancing medical technology and contributing to the healthcare industry. It utilizes a hiring indicator of “yes” for personnel and resources.